S

Spruce Biosciences Inc
D

SPRB

159.000
USD
-15.01
(-8.63%)
مغلق
حجم التداول
1,599
الربح لكل سهم
-51
العائد الربحي
-
P/E
-2
حجم السوق
89,595,069
المقالات

العنوان: Spruce Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.